Holen Sie sich die Stockscreener-App
26.57
2.96%
-0.81
Vorhandelsmarkt:
26.54
-0.03
-0.11%
Genmab Adr Aktie (GMAB) Neueste Nachrichten
First Trust Advisors LP Sells 82,922 Shares of Genmab A/S Sponsored ADR $GMAB - MarketBeat
Genmab (GMAB) Upgraded to Strong Buy: Here's Why - MSN
Correction to Company Announcement No. 13 of March 2, 2026 - GlobeNewswire Inc.
Stocks With Rising Relative Strength: Genmab ADR - Investor's Business Daily
Genmab ADR shows improved relative strength; still shy of benchmark - MSN
Genmab ADR Shows Improved Relative Strength; Still Shy Of Benchmark - Investor's Business Daily
GENMAB A/S -SP ADR (NASDAQ:GMAB) Emerges as a Peter Lynch-Style GARP Investment - ChartMill
Genmab (GMAB) Reports 19% Revenue Growth to $3.7B in 2025 Driven by Proprietary Medicine Sales - Finviz
Genmab A/S (NASDAQ:GMAB) Given New $40.00 Price Target at HC Wainwright - Defense World
Top 3 Health Care stocks That Could Lead To Your Biggest Gains In Q1 - Sahm
Genmab A/S Sponsored ADR (NASDAQ:GMAB) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Genmab A/S (NASDAQ:GMAB) Coverage Initiated by Analysts at Jefferies Financial Group - Defense World
Genmab A/S Q4 Earnings Call Highlights - Yahoo Finance
Genmab A/S (NASDAQ:GMAB) Given Equal Weight Rating at Morgan Stanley - Defense World
Genmab A/S Sponsored ADR (NASDAQ:GMAB) Sees Significant Decrease in Short Interest - MarketBeat
279,932 Shares in Genmab A/S Sponsored ADR $GMAB Bought by Cibc World Market Inc. - MarketBeat
Is the Options Market Predicting a Spike in Genmab Stock? - TradingView
H.C. Wainwright Bullish on Genmab A/S (GMAB) on Robust Sales for DARZALEX - Finviz
Envestnet Asset Management Inc. Purchases 60,336 Shares of Genmab A/S Sponsored ADR $GMAB - MarketBeat
RFG Advisory LLC Takes $1.30 Million Position in Genmab A/S Sponsored ADR $GMAB - MarketBeat
Where is Genmab A/S (GMAB) Headed According to Wall Street? - Finviz
Oppenheimer Asset Management Inc. Acquires 61,311 Shares of Genmab A/S Sponsored ADR $GMAB - MarketBeat
Genmab A/S (NASDAQ:GMAB): A GARP Case Study in Affordable Biotech Growth - ChartMill
Federated Hermes Inc. Makes New Investment in Genmab A/S Sponsored ADR $GMAB - MarketBeat
What is HC Wainwright’s Estimate for Genmab A/S Q4 Earnings? - Defense World
What is HC Wainwright's Estimate for Genmab A/S Q4 Earnings? - MarketBeat
EPKINLY Trial Results Prompt Price Target Cut for Genmab (GMAB) - Finviz
HC Wainwright Boosts Earnings Estimates for Genmab A/S - MarketBeat
GENMAB A/S (NASDAQ:GMAB) Stands Out as a Peter Lynch-Style GARP Investment - Chartmill
Genmab A/S (NASDAQ:GMAB) Shares Gap DownHere's What Happened - MarketBeat
GENMAB A/S -SP ADR (NASDAQ:GMAB) Combines Strong Growth with Bullish Technical Formation - Chartmill
GENMAB A/S (NASDAQ:GMAB) Presents a Compelling Blend of Strong Fundamentals and Bullish Technicals - ChartMill
Genmab A/S Sponsored ADR (NASDAQ:GMAB) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Genmab A/S Sponsored ADR (NASDAQ:GMAB) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Alkermes Stock Earns Technical Rating Upgrade - Investor's Business Daily
Genmab A/S (GMAB) Shares Gain Analyst Support as Deutsche Bank Sees Oncology Upside - Finviz
Ascendis Pharma ADR shows rising price performance with jump to 83 RS rating - MSN
Genmab A/S (GMAB): A Bull Case Theory - Finviz
Oric Pharmaceuticals Stock Sees Healthy RS Rating Jump To 80 - Investor's Business Daily
Biotech Stocks To Watch And Pharma Industry News - Investor's Business Daily
Eagle Global Advisors LLC Buys 34,175 Shares of Genmab A/S Sponsored ADR $GMAB - MarketBeat
Genmab ADR Joins Rank Of Stocks With RS Ratings Over 90 - Investor's Business Daily
Genmab A/S (NASDAQ:GMAB) Hits New 52-Week HighTime to Buy? - MarketBeat
Genmab A/S (OTCMKTS:GNMSF) Reaches New 1-Year HighShould You Buy? - MarketBeat
Moderna Stock Gets Healthy Relative Strength Rating Jump - Investor's Business Daily
Genmab (GMAB) Upgraded to Buy: Here's What You Should Know - MSN
Quoin Pharm ADR clears technical benchmark, hitting 90-plus RS rating - MSN
Genmab A/SAmerican Depositary Shares (NQ: GMAB - FinancialContent
Genmab A/S (OTCMKTS:GNMSF) Reaches New 52-Week HighHere's What Happened - MarketBeat
Stocks To Watch: Immunocore Holdings ADR Sees RS Rating Rise To 83 - MSN
Genmab A/S (NASDAQ:GMAB) Shares Down 3.5% – Here’s Why - Defense World
Genmab A/S (NASDAQ:GMAB) Stock Price Down 3.5%Time to Sell? - MarketBeat
1.76%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):